Single luminal epithelial progenitors can generate prostate organoids in culture
The intrinsic ability to exhibit self-organizing morphogenetic properties in ex vivo culture may represent a general property of tissue stem cells. Here we show that single luminal stem/progenitor cells can generate prostate organoids in a three-dimensional culture system in the absence of stroma. O...
Gespeichert in:
Veröffentlicht in: | Nature cell biology 2014-10, Vol.16 (10), p.951-961 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The intrinsic ability to exhibit self-organizing morphogenetic properties in
ex vivo
culture may represent a general property of tissue stem cells. Here we show that single luminal stem/progenitor cells can generate prostate organoids in a three-dimensional culture system in the absence of stroma. Organoids generated from CARNs (castration-resistant Nkx3.1-expressing cells) or normal prostate epithelia exhibit tissue architecture containing luminal and basal cells, undergo long-term expansion in culture and exhibit functional androgen receptor signalling. Lineage-tracing demonstrates that luminal cells are favoured for organoid formation and generate basal cells in culture. Furthermore, tumour organoids can initiate from CARNs after oncogenic transformation and from mouse models of prostate cancer, and can facilitate analyses of drug response. Finally, we provide evidence supporting the feasibility of organoid studies of human prostate tissue. Our studies underscore the progenitor properties of luminal cells, and identify
in vitro
approaches for studying prostate biology.
Shen and colleagues report the
in vitro
generation of organoids from mouse luminal epithelial progenitor cells and normal or transformed prostate tissue, and extend this approach to the formation of normal and tumour organoids of human origin |
---|---|
ISSN: | 1465-7392 1476-4679 |
DOI: | 10.1038/ncb3047 |